Contents of the Briefing Package

Pulmonary-Allergy Drugs Advisory Committee

September 6, 2002

 

  1. Division Director’s Memorandum
  2. Disclaimer Statement
  3. Clinical Briefing Document
  4. Clinical Pharmacology and Biopharmaceutics Briefing Document
  5. Reference Articles:
  1. Sample labels of products currently approved for COPD: